C Burton Selected Research

C Burton Research Topics

3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 08/2005
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2006 - 08/2005
3	Atherosclerosis 08/2001 - 04/2000
2	Neoplasms (Cancer) 07/2018 - 10/2012
1	Hypotension (Low Blood Pressure) 01/2022
1	Wound Infection (Wound Infections) 01/2022
1	Margins of Excision 01/2022
1	Hypothermia 01/2022
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Parkinson Disease (Parkinson's Disease) 05/2020
1	Hepatic Encephalopathy 05/2014
1	Hepatitis 05/2014
1	Liver Diseases (Liver Disease) 05/2014
1	Diabetic Neuropathies (Diabetic Neuropathy) 03/2013
1	Occupational Asthma 08/2011
1	Rhinitis 08/2011
1	Cognitive Dysfunction 07/2009
1	Stroke (Strokes) 06/2007
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2005
1	Lymphoma (Lymphomas) 08/2005
1	Cardiotoxicity 08/2005
1	HIV Infections (HIV Infection) 05/2001
1	Cystic Kidney Diseases (Cystic Kidney Disease) 03/2001
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2001
1	Atherosclerotic Plaque (Atheroma) 09/2000

3	Apolipoproteins E (ApoE)IBA 08/2001 - 04/2000
2	ApolipoproteinsIBA 09/2000 - 04/2000
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Fluorine-18IBA 01/2021
1	R-CHOP protocolIBA 01/2020
1	NSC 30705 (RQ2)IBA 07/2018
1	GraphiteIBA 05/2014
1	ManganeseIBA 05/2014
1	Antidepressive Agents (Antidepressants)IBA 03/2013
1	Psychotropic Drugs (Psychoactive Drugs)IBA 10/2012
1	milk-derived factorIBA 08/2011
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2006
1	Vincristine (Oncovin)FDA LinkGeneric 08/2005
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 08/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2005
1	Daunorubicin (Cerubidine)FDA LinkGeneric 08/2005
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2005
1	Prednisolone (Predate)FDA LinkGeneric 08/2005
1	LipidsIBA 08/2001
1	Complement System Proteins (Complement)IBA 08/2001
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 08/2001
1	CCR5 Receptors (CCR5 Receptor)IBA 05/2001
1	SaltsIBA 03/2001
1	Nitric Oxide Synthase (NO Synthase)IBA 09/2000
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2000
1	LipopolysaccharidesIBA 04/2000

3	Drug Therapy (Chemotherapy) 01/2020 - 08/2005
1	Language Therapy (Language Training) 05/2020
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 05/2014
1	Cognitive Training 07/2009
1	Palliative Care (Palliative Therapy) 06/2007
1	PMitCEBO protocol 03/2006
1	Chemoprevention 10/2005